Share-Based Compensation (SARs Activity) (Details) (Stock Appreciation Rights (SARs), USD $)	9 Months Ended
	Nov. 01, 2014	Nov. 02, 2013
Stock Appreciation Rights (SARs)
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Other than Options, Exercises in Period, Intrinsic Value	$ 1,500,000	$ 8,500,000
Number of Underlying Shares Outstanding [Roll Forward]
Number of Underlying Shares, Beginning Balance	8,982,959
Number of Underlying Shares, Granted	395,300
Number of Underlying Shares, Exercised	(92,475)
Number of Underlying Shares, Forfeited	(198,275)
Number of Underlying Shares, Ending Balance	9,087,509
Weighted-Average Exercise Price [Roll Forward]
Weighted-Average Grant Date Fair Value, Beginning Balance	$ 40.76
Fair value (in dollars per share)	$ 38.62
Weighted-Average Exercise Price, Exercised	$ 26.92
Weighted-Average Exercise Price, Forfeited or expired	$ 47.92
Weighted-Average Grant Date Fair Value, Ending Balance	$ 40.65
Aggregate Intrinsic Value, Outstanding	21,081,713
Weighted-Average Remaining Contractual Life, Outstanding	2 years 9 months
Number of Underlying shares, Stock appreciation rights exercisable	8,352,634
Number of Underlying Shares, Stock appreciation rights expected to become exercisable	666,668
Weighted-Average Exercise Price, Stock appreciation rights exercisable	$ 40.38
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable	$ 43.96
Aggregate Intrinsic Value, Stock appreciation rights exercisable	21,068,363
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable	$ 10,598
Weighted-Average Remaining Contractual Life, Stock appreciation rights exercisable	2 years 4 months
Weighted Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	8 years 7 months